These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29303717)

  • 1. 2017: a year in review.
    Yaqub F
    Lancet; 2017 Dec; 390(10114):2753-2754. PubMed ID: 29303717
    [No Abstract]   [Full Text] [Related]  

  • 2. CAR T-cells for relapsed B-cell ALL in children and young adults.
    Stirrups R
    Lancet Oncol; 2018 Mar; 19(3):e144. PubMed ID: 29429913
    [No Abstract]   [Full Text] [Related]  

  • 3. CAR T-cells for relapsed B-cell ALL in adults.
    Gilbert JA
    Lancet Oncol; 2018 Mar; 19(3):e143. PubMed ID: 29429915
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential allogeneic and autologous CAR-T-cell therapy to treat an immune-compromised leukemic patient.
    Zhang JP; Zhang R; Tsao ST; Liu YC; Chen X; Lu DP; Castillo P; Chang LJ
    Blood Adv; 2018 Jul; 2(14):1691-1695. PubMed ID: 30026294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Make plans to eliminate cholera outbreaks.
    Zaidi A
    Nature; 2017 Oct; 550(7674):9. PubMed ID: 28980651
    [No Abstract]   [Full Text] [Related]  

  • 6. BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia.
    Amro Elshoury ; Wallace PK; Borowitz MJ; Kader A; Choi C; Ho C; Balderman S; Ross M; Hahn T; O'Neill V; McCarthy PL; Chen GL
    Bone Marrow Transplant; 2018 May; 53(5):651-653. PubMed ID: 29343836
    [No Abstract]   [Full Text] [Related]  

  • 7. The Promise and Challenges of CAR-T Gene Therapy.
    Kuehn BM
    JAMA; 2017 Dec; 318(22):2167-2169. PubMed ID: 29167891
    [No Abstract]   [Full Text] [Related]  

  • 8. TSLPR: a new CAR in the showroom for B-ALL.
    Davies DM; Maher J
    Blood; 2015 Jul; 126(5):567-9. PubMed ID: 26228169
    [No Abstract]   [Full Text] [Related]  

  • 9. CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?
    Pegram HJ; Smith EL; Rafiq S; Brentjens RJ
    Immunotherapy; 2015; 7(5):545-61. PubMed ID: 26065479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hunger, Health, and Compassion.
    Gostin LO
    JAMA; 2017 May; 317(19):1939-1940. PubMed ID: 28510667
    [No Abstract]   [Full Text] [Related]  

  • 11. Tisagenlecleucel (Kymriah) for ALL.
    Med Lett Drugs Ther; 2017 Oct; 59(1532):177-178. PubMed ID: 29039821
    [No Abstract]   [Full Text] [Related]  

  • 12. Tisagenlecleucel in pediatric patients with acute lymphoblastic leukemia.
    Maude SL
    Clin Adv Hematol Oncol; 2018 Oct; 16(10):664-666. PubMed ID: 30543595
    [No Abstract]   [Full Text] [Related]  

  • 13. Yemen in a Time of Cholera: Current Situation and Challenges.
    Al-Mekhlafi HM
    Am J Trop Med Hyg; 2018 Jun; 98(6):1558-1562. PubMed ID: 29557331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia.
    Liu S; Deng B; Yin Z; Pan J; Lin Y; Ling Z; Wu T; Chen D; Chang AH; Gao Z; Song Y; Zhao Y; Tong C
    Blood Cancer J; 2020 Feb; 10(2):15. PubMed ID: 32029707
    [No Abstract]   [Full Text] [Related]  

  • 15. Late Events After CD-19 CAR-T Treatment.
    Hossain NM; Nishimura MI
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):e1-e2. PubMed ID: 31669398
    [No Abstract]   [Full Text] [Related]  

  • 16. Health in the Horn of Africa: a collective response needed.
    Lancet; 2011 Aug; 378(9791):541. PubMed ID: 21840443
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of surface CD3 expression in allogeneic CAR T-cells.
    Margolskee E; Pillai V
    Am J Hematol; 2020 Sep; 95(9):1115-1116. PubMed ID: 32129509
    [No Abstract]   [Full Text] [Related]  

  • 18. CART attack.
    Pillai V; Maude SL
    Blood; 2017 Jul; 130(2):229. PubMed ID: 28705860
    [No Abstract]   [Full Text] [Related]  

  • 19. Yemen needs a concrete plan-now.
    The Lancet Global Health
    Lancet Glob Health; 2019 Jan; 7(1):e1. PubMed ID: 30528294
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation.
    Chen Y; Cheng Y; Suo P; Yan C; Wang Y; Chen Y; Han W; Xu L; Zhang X; Liu K; Chang L; Xiao L; Huang X
    Br J Haematol; 2017 Nov; 179(4):598-605. PubMed ID: 29076142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.